2018 Q3 Form 10-Q Financial Statement
#000156459018021566 Filed on August 14, 2018
Income Statement
Concept | 2018 Q3 | 2018 Q2 | 2017 Q2 |
---|---|---|---|
Revenue | $198.0K | $126.0K | $0.00 |
YoY Change | |||
Cost Of Revenue | $246.0K | $246.0K | $0.00 |
YoY Change | |||
Gross Profit | -$48.00K | -$120.0K | $0.00 |
YoY Change | |||
Gross Profit Margin | -24.24% | -95.24% | |
Selling, General & Admin | $1.090M | $930.0K | $1.270M |
YoY Change | 4.81% | -26.77% | |
% of Gross Profit | |||
Research & Development | $5.314M | $5.512M | $3.392M |
YoY Change | 23.87% | 62.5% | |
% of Gross Profit | |||
Depreciation & Amortization | $54.00K | $56.00K | $50.00M |
YoY Change | 8.0% | -99.89% | |
% of Gross Profit | |||
Operating Expenses | $5.314M | $5.512M | $3.392M |
YoY Change | -0.3% | 62.5% | |
Operating Profit | -$6.454M | -$6.557M | -$4.666M |
YoY Change | 21.09% | 40.53% | |
Interest Expense | $44.00K | $81.00K | $355.0K |
YoY Change | -122.0% | -77.18% | |
% of Operating Profit | |||
Other Income/Expense, Net | $70.00K | $0.00 | -$7.000K |
YoY Change | -100.0% | ||
Pretax Income | -$6.600M | -$6.608M | -$4.879M |
YoY Change | 19.13% | 35.44% | |
Income Tax | $0.00 | $0.00 | $0.00 |
% Of Pretax Income | |||
Net Earnings | -$6.600M | -$6.608M | -$4.879M |
YoY Change | 19.13% | 35.44% | |
Net Earnings / Revenue | -3333.33% | -5244.44% | |
Basic Earnings Per Share | |||
Diluted Earnings Per Share | -$575.4K | -$569.8K | -$425.5K |
COMMON SHARES | |||
Basic Shares Outstanding | 11.48M | ||
Diluted Shares Outstanding |
Balance Sheet
Concept | 2018 Q3 | 2018 Q2 | 2017 Q2 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $27.38M | $1.300M | |
YoY Change | |||
Cash & Equivalents | $11.26M | $1.298M | $1.166M |
Short-Term Investments | $16.12M | ||
Other Short-Term Assets | $1.560M | $800.0K | |
YoY Change | |||
Inventory | |||
Prepaid Expenses | |||
Receivables | $403.0K | $352.0K | |
Other Receivables | $0.00 | $0.00 | |
Total Short-Term Assets | $29.34M | $2.449M | |
YoY Change | |||
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $544.0K | $541.0K | |
YoY Change | |||
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | $1.730M | ||
YoY Change | |||
Total Long-Term Assets | $544.0K | $2.266M | |
YoY Change | |||
TOTAL ASSETS | |||
Total Short-Term Assets | $29.34M | $2.449M | |
Total Long-Term Assets | $544.0K | $2.266M | |
Total Assets | $29.88M | $4.715M | |
YoY Change | |||
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $2.276M | $3.609M | |
YoY Change | |||
Accrued Expenses | $3.818M | $3.843M | |
YoY Change | |||
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $1.280M | |
YoY Change | |||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $6.136M | $8.833M | |
YoY Change | |||
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | |
YoY Change | |||
Other Long-Term Liabilities | $0.00 | $30.00K | |
YoY Change | |||
Total Long-Term Liabilities | $0.00 | $30.00K | |
YoY Change | |||
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $6.136M | $8.833M | |
Total Long-Term Liabilities | $0.00 | $30.00K | |
Total Liabilities | $30.10M | $8.864M | |
YoY Change | |||
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$201.7M | ||
YoY Change | |||
Common Stock | $1.000K | ||
YoY Change | |||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | $11.00K | ||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | -$220.0K | -$139.8M | |
YoY Change | |||
Total Liabilities & Shareholders Equity | $29.88M | $4.715M | |
YoY Change |
Cashflow Statement
Concept | 2018 Q3 | 2018 Q2 | 2017 Q2 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$6.600M | -$6.608M | -$4.879M |
YoY Change | 19.13% | 35.44% | |
Depreciation, Depletion And Amortization | $54.00K | $56.00K | $50.00M |
YoY Change | 8.0% | -99.89% | |
Cash From Operating Activities | -$7.220M | -$5.330M | -$5.780M |
YoY Change | 52.64% | -7.79% | |
INVESTING ACTIVITIES | |||
Capital Expenditures | -$10.00K | -$10.00K | -$60.00K |
YoY Change | 0.0% | -83.33% | |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | -$16.09M | ||
YoY Change | |||
Cash From Investing Activities | -$16.10M | -$10.00K | -$60.00K |
YoY Change | 160900.0% | -83.33% | |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 33.28M | 3.720M | 5.990M |
YoY Change | 732.0% | -37.9% | |
NET CHANGE | |||
Cash From Operating Activities | -7.220M | -5.330M | -5.780M |
Cash From Investing Activities | -16.10M | -10.00K | -60.00K |
Cash From Financing Activities | 33.28M | 3.720M | 5.990M |
Net Change In Cash | 9.960M | -1.620M | 150.0K |
YoY Change | -1445.95% | -1180.0% | |
FREE CASH FLOW | |||
Cash From Operating Activities | -$7.220M | -$5.330M | -$5.780M |
Capital Expenditures | -$10.00K | -$10.00K | -$60.00K |
Free Cash Flow | -$7.210M | -$5.320M | -$5.720M |
YoY Change | 52.75% | -6.99% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2017Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
160000000 | |
CY2017Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
1103396 | |
CY2017Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
1102560 | |
CY2017Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2018Q2 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
126000 | |
CY2018Q2 | us-gaap |
Treasury Stock Common Shares
TreasuryStockCommonShares
|
836 | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
7678000 | ||
CY2018Q3 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
11475749 | |
CY2018Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1298000 | |
CY2017Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
4180000 | |
CY2018Q2 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
352000 | |
CY2017Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
117000 | |
CY2018Q2 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
799000 | |
CY2017Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
677000 | |
CY2018Q2 | us-gaap |
Assets Current
AssetsCurrent
|
2449000 | |
CY2017Q4 | us-gaap |
Assets Current
AssetsCurrent
|
4974000 | |
CY2018Q2 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
541000 | |
CY2017Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
601000 | |
CY2018Q2 | us-gaap |
Deferred Offering Costs
DeferredOfferingCosts
|
1725000 | |
CY2018Q2 | us-gaap |
Assets
Assets
|
4715000 | |
CY2017Q4 | us-gaap |
Assets
Assets
|
5575000 | |
CY2018Q2 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
3609000 | |
CY2017Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1910000 | |
CY2018Q2 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
3843000 | |
CY2017Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
1957000 | |
CY2018Q2 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
104000 | |
CY2017Q4 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
298000 | |
CY2018Q2 | us-gaap |
Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
|
1277000 | |
CY2018Q2 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
8833000 | |
CY2017Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
4165000 | |
CY2017Q4 | us-gaap |
Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
|
2813000 | |
CY2018Q2 | us-gaap |
Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
|
31000 | |
CY2017Q4 | us-gaap |
Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
|
369000 | |
CY2018Q2 | us-gaap |
Liabilities
Liabilities
|
8864000 | |
CY2018Q2 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2018Q2 | us-gaap |
Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
|
111718000 | |
CY2017Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
7684000 | |
CY2017Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-187249000 | |
CY2017Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-125453000 | |
CY2018Q2 | us-gaap |
Minority Interest
MinorityInterest
|
23963000 | |
CY2017Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2017Q4 | us-gaap |
Liabilities
Liabilities
|
7347000 | |
CY2017Q4 | us-gaap |
Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
|
111718000 | |
CY2018Q2 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
7684000 | |
CY2018Q2 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
54216000 | |
CY2017Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
54123000 | |
CY2018Q2 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
11000 | |
CY2018Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-201719000 | |
CY2017Q4 | us-gaap |
Minority Interest
MinorityInterest
|
11963000 | |
CY2018Q2 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-115867000 | |
CY2017Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-113490000 | |
CY2018Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
4715000 | |
CY2017Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
5575000 | |
CY2018Q2 | us-gaap |
Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
|
0.001 | |
CY2017Q4 | us-gaap |
Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
|
0.001 | |
CY2018Q2 | us-gaap |
Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
|
66317000 | |
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
61000 | ||
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
57000 | ||
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-61000 | ||
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-57000 | ||
us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
12000 | ||
us-gaap |
Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
|
-1592000 | ||
ck0001205922 |
Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
|
-16062000 | ||
ck0001205922 |
Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
|
-12188000 | ||
CY2018Q2 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-6.72 | |
CY2017Q2 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-5.15 | |
us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-11.07 | ||
CY2018Q2 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
1103144 | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
60000 | ||
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
235000 | ||
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-101000 | ||
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
160000 | ||
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
666000 | ||
us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
1014000 | ||
us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-334000 | ||
CY2017Q2 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
1101719 | |
us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
1101319 | ||
us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
1220000 | ||
us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-6000 | ||
us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-194000 | ||
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-10499000 | ||
CY2017Q4 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
11000 | |
CY2018Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-139830000 | |
CY2017Q2 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-7000 | |
CY2018Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-6608000 | |
CY2018Q2 | us-gaap |
Profit Loss
ProfitLoss
|
-6608000 | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-14470000 | ||
CY2018Q2 | us-gaap |
Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
|
-800000 | |
CY2017Q2 | us-gaap |
Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
|
-800000 | |
us-gaap |
Noncontrolling Interest Increase From Sale Of Parent Equity Interest
NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest
|
12000000 | ||
us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
5000 | ||
us-gaap |
Depreciation
Depreciation
|
112000 | ||
us-gaap |
Depreciation
Depreciation
|
98000 | ||
us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
284000 | ||
us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
564000 | ||
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
88000 | ||
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-10408000 | ||
us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
3976000 | ||
us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
5000 | ||
us-gaap |
Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
|
4000000 | ||
us-gaap |
Proceeds From Contributed Capital
ProceedsFromContributedCapital
|
12000000 | ||
ck0001205922 |
Payment Of Deferred Offering Costs
PaymentOfDeferredOfferingCosts
|
327000 | ||
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
9970000 | ||
us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-2882000 | ||
us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-495000 | ||
CY2016Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1661000 | |
CY2017Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1166000 | |
ck0001205922 |
Deferred Offering Costs In Accounts Payable And Accrued Expenses
DeferredOfferingCostsInAccountsPayableAndAccruedExpenses
|
1360000 | ||
CY2017Q4 | us-gaap |
Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
|
66317000 | |
CY2018Q2 | us-gaap |
Temporary Equity Shares Issued
TemporaryEquitySharesIssued
|
53089959 | |
CY2017Q4 | us-gaap |
Temporary Equity Shares Issued
TemporaryEquitySharesIssued
|
53089959 | |
CY2018Q2 | us-gaap |
Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
|
53089796 | |
CY2017Q4 | us-gaap |
Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
|
53089796 | |
CY2018Q2 | us-gaap |
Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
|
141853000 | |
CY2017Q4 | us-gaap |
Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
|
140261000 | |
CY2018Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2018Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
160000000 | |
CY2018Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
1104096 | |
CY2018Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
1103260 | |
CY2018Q2 | us-gaap |
Treasury Stock Preferred Shares
TreasuryStockPreferredShares
|
163 | |
CY2017Q4 | us-gaap |
Treasury Stock Preferred Shares
TreasuryStockPreferredShares
|
163 | |
CY2017Q4 | us-gaap |
Treasury Stock Common Shares
TreasuryStockCommonShares
|
836 | |
us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
332000 | ||
CY2018Q2 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
246000 | |
us-gaap |
Cost Of Revenue
CostOfRevenue
|
486000 | ||
CY2018Q2 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
5512000 | |
CY2017Q2 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
3392000 | |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
9966000 | ||
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
7231000 | ||
CY2018Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
925000 | |
CY2017Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1274000 | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-12266000 | ||
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-9575000 | ||
us-gaap |
Costs And Expenses
CostsAndExpenses
|
12598000 | ||
us-gaap |
Costs And Expenses
CostsAndExpenses
|
9575000 | ||
CY2018Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-6557000 | |
CY2017Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-4666000 | |
CY2018Q2 | us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
30000 | |
CY2017Q2 | us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
149000 | |
us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
338000 | ||
us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
-371000 | ||
CY2018Q2 | us-gaap |
Interest Expense
InterestExpense
|
81000 | |
CY2017Q2 | us-gaap |
Interest Expense
InterestExpense
|
355000 | |
us-gaap |
Interest Expense
InterestExpense
|
348000 | ||
us-gaap |
Interest Expense
InterestExpense
|
627000 | ||
us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
-2180000 | ||
us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-14000 | ||
us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-23000 | ||
CY2017Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-4879000 | |
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-14470000 | ||
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-10596000 | ||
CY2017Q2 | us-gaap |
Profit Loss
ProfitLoss
|
-4879000 | |
us-gaap |
Profit Loss
ProfitLoss
|
-14470000 | ||
us-gaap |
Profit Loss
ProfitLoss
|
-10596000 | ||
us-gaap |
Net Income Loss
NetIncomeLoss
|
-10596000 | ||
us-gaap |
Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
|
-1592000 | ||
CY2018Q2 | ck0001205922 |
Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
|
-7408000 | |
CY2017Q2 | ck0001205922 |
Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
|
-5679000 | |
us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-14.56 | ||
us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
1102853 | ||
us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
84000 | ||
CY2018Q2 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
56000000 | |
CY2017Q2 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
50000000 | |
us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
112000000 | ||
us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
98000000 | ||
CY2018Q2 | ck0001205922 |
Accrued Clinical Trial Cost Current
AccruedClinicalTrialCostCurrent
|
2314000 | |
CY2017Q4 | ck0001205922 |
Accrued Clinical Trial Cost Current
AccruedClinicalTrialCostCurrent
|
891000 | |
CY2018Q2 | ck0001205922 |
Accrued Deferred Offering Costs Current
AccruedDeferredOfferingCostsCurrent
|
666000 | |
CY2018Q2 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
290000 | |
CY2017Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
239000 | |
CY2018Q2 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
273000 | |
CY2017Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
311000 | |
CY2018Q2 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
256000 | |
CY2017Q4 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
192000 | |
us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
700 | ||
CY2017Q4 | ck0001205922 |
Share Based Compensation Arrangement By Share Based Payment Award Options Available For Grant Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantOutstandingNumber
|
19034 | |
us-gaap |
Use Of Estimates
UseOfEstimates
|
<div> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-top:12pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:5.24%;">These condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States (“U.S. GAAP”). The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities as of the date of the condensed consolidated financial statements and the reported amount of expenses during the reporting period. Such management estimates include those relating to assumptions used in the valuation of stock option awards, the valuation of derivative instruments, and valuation allowances against deferred income tax assets. Actual results could differ from those estimates. </p></div> | ||
CY2018Q2 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
44000 | |
CY2017Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
324000 | |
us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Concentration of Credit Risk, Other Risks and Uncertainties </p> <p style="margin-top:12pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:5.24%;">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents. Cash equivalents are deposited in interest-bearing money market accounts. Although the Company deposits the cash with multiple financial institutions, cash balances may occasionally be in excess of the amounts insured by the Federal Deposit Insurance Corporation. Management believes the financial risk associated with these balances is minimal and has not experienced any losses to date. </p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company depends on third-party manufacturers for the manufacture of drug substance and drug product for clinical trials. The Company also relies on certain third parties for its supply chain. Disputes with these third- party manufacturers or shortages in goods or services from third-party suppliers could delay the manufacturing of the Company’s product candidates and adversely impact its results of operations. </p></div> | ||
CY2017Q4 | us-gaap |
Derivative Liabilities
DerivativeLiabilities
|
369000 | |
us-gaap |
Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Period Increase Decrease
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease
|
-338000 | ||
CY2018Q2 | us-gaap |
Derivative Liabilities
DerivativeLiabilities
|
31000 | |
CY2018Q2 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
49000 | |
CY2017Q2 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
322000 | |
us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
284000 | ||
us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
564000 | ||
CY2018Q2 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
|
1890000 | |
CY2018Q2 | us-gaap |
Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
|
1890000 | |
CY2018Q2 | us-gaap |
Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
|
390000 | |
CY2018Q2 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
223000 | |
CY2018Q2 | us-gaap |
Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
|
1277000 | |
CY2018Q2 | us-gaap |
Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
|
1277000 | |
ck0001205922 |
Royalty Payment Percentage Of Net Sales
RoyaltyPaymentPercentageOfNetSales
|
0.01 | ||
CY2018Q2 | ck0001205922 |
Operating Lease Monthly Rental Payments
OperatingLeaseMonthlyRentalPayments
|
14000 | |
CY2018Q2 | us-gaap |
Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
|
56000 | |
CY2017Q2 | us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
42000 | |
CY2018Q2 | us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
42000 | |
us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
84000 | ||
CY2017Q4 | us-gaap |
Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
|
9341111 | |
CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
420956 | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
28000 | ||
CY2018Q2 | us-gaap |
Cash
Cash
|
1300000 | |
ck0001205922 |
Proceeds From Issuance Initial Public Offering Gross
ProceedsFromIssuanceInitialPublicOfferingGross
|
40000000 | ||
CY2018Q2 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
6754000 | |
CY2017Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
6702000 | |
CY2018Q2 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
6213000 | |
CY2017Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
6101000 | |
ck0001205922 |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Shares Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantSharesGranted
|
-28000 | ||
ck0001205922 |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Shares Canceled
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantSharesCanceled
|
44557 | ||
CY2018Q2 | ck0001205922 |
Share Based Compensation Arrangement By Share Based Payment Award Options Available For Grant Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantOutstandingNumber
|
35591 | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
44557 | ||
CY2018Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
403699 | |
CY2018Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
354139 | |
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
13.60 | ||
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
7.10 | ||
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
7.10 | ||
CY2018Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
9.71 | |
CY2017 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P7Y4M24D | |
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P7Y | ||
CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
5021000 | |
CY2018Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
4598000 | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
15.63 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
0 | ||
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
|
143000 | ||
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
|
76000 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
11000 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
10000 | ||
CY2018Q2 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
|
515000 | |
CY2017Q4 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
|
216000 | |
ck0001205922 |
Share Based Compensation Arrangement By Share Based Payment Award Options Maximum Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMaximumContractualTerm
|
P10Y | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0.00 | ||
CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.35 | |
us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.21 | ||
CY2016 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | |
CY2017 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | |
CY2017 | ck0001205922 |
Tax Cuts And Jobs Act Change In Tax Rate Deferred Tax Assets Provisional Income Tax Benefit
TaxCutsAndJobsActChangeInTaxRateDeferredTaxAssetsProvisionalIncomeTaxBenefit
|
20700000 | |
CY2017Q4 | us-gaap |
Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
|
0 | |
CY2017Q2 | us-gaap |
Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
|
800000 | |
us-gaap |
Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
|
1592000 | ||
us-gaap |
Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
|
1592000 | ||
ck0001205922 |
Number Of Business Activity
NumberOfBusinessActivity
|
1 | ||
ck0001205922 |
Number Of Segment Managers For Operations Or Operating Results
NumberOfSegmentManagersForOperationsOrOperatingResults
|
0 | ||
CY2016 | us-gaap |
Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
|
1.00 | |
CY2017 | us-gaap |
Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
|
1.00 | |
us-gaap |
Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
|
1.00 |